Mc Guire Investment Group, LLC Vertex Pharmaceuticals Inc Transaction History

Mc Guire Investment Group, LLC

$636 Million
Q1 2025

A detailed history of Mc Guire Investment Group, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Mc Guire Investment Group, LLC holds 5,831 shares of VRTX stock, worth $2.88 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares

5,831

Previous 6,009 2.96%

Holding current value

$2.88 Million

Previous $2.42 Million 16.83%

% of portfolio

0.44%

Previous 0.37%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 24, 2025	SELL	$402.49 - $513.76 $71,643 - $91,449	-178 Reduced 2.96%	5,831 $2.83 Million
Q4 2024 Jan 21, 2025	SELL	$396.64 - $516.74 $3,966 - $5,167	-10 Reduced 0.17%	6,009 $2.42 Million
Q2 2024 Jul 23, 2024	SELL	$392.81 - $485.53 $392 - $485	-1 Reduced 0.02%	6,019 $2.82 Million
Q3 2023 Oct 12, 2023	SELL	$338.18 - $362.46 $97,395 - $104,388	-288 Reduced 4.57%	6,020 $2.09 Million
Q1 2023 Apr 20, 2023	SELL	$283.23 - $323.1 $44,183 - $50,403	-156 Reduced 2.41%	6,308 $1.99 Million
Q3 2022 Oct 13, 2022	SELL	$273.83 - $305.53 $821 - $916	-3 Reduced 0.05%	6,464 $1.87 Million
Q2 2022 Jul 15, 2022	SELL	$234.96 - $292.55 $75,422 - $93,908	-321 Reduced 4.73%	6,467 $1.82 Million
Q4 2021 Jan 13, 2022	SELL	$177.01 - $223.45 $38,588 - $48,712	-218 Reduced 3.11%	6,788 $1.49 Million
Q3 2021 Oct 19, 2021	SELL	$181.39 - $202.99 $21,404 - $23,952	-118 Reduced 1.66%	7,006 $1.27 Million
Q2 2021 Jul 16, 2021	SELL	$187.49 - $221.1 $20,623 - $24,321	-110 Reduced 1.52%	7,124 $1.44 Million
Q1 2021 Apr 20, 2021	SELL	$207.02 - $241.31 $828 - $965	-4 Reduced 0.06%	7,234 $1.56 Million
Q4 2020 Jan 13, 2021	BUY	$207.01 - $276.09 $22,150 - $29,541	107 Added 1.5%	7,238 $1.71 Million
Q3 2020 Oct 19, 2020	SELL	$255.65 - $303.1 $38,347 - $45,465	-150 Reduced 2.06%	7,131 $1.94 Million
Q2 2020 Jul 14, 2020	SELL	$225.48 - $295.8 $39,459 - $51,765	-175 Reduced 2.35%	7,281 $2.11 Million
Q1 2020 Apr 02, 2020	SELL	$199.77 - $247.81 $9,788 - $12,142	-49 Reduced 0.65%	7,456 $1.77 Million
Q4 2019 Jan 07, 2020	SELL	$166.71 - $223.91 $12,669 - $17,017	-76 Reduced 1.0%	7,505 $1.64 Million
Q3 2019 Oct 25, 2019	SELL	$166.23 - $187.09 $30,253 - $34,050	-182 Reduced 2.34%	7,581 $1.28 Million
Q2 2019 Jul 25, 2019	SELL	$164.61 - $190.37 $37,037 - $42,833	-225 Reduced 2.82%	7,763 $1.42 Million
Q1 2019 Apr 23, 2019	SELL	$163.73 - $194.7 $18,992 - $22,585	-116 Reduced 1.43%	7,988 $1.47 Million
Q4 2018 Jan 28, 2019	BUY	$151.91 - $192.21 $1,519 - $1,922	10 Added 0.12%	8,104 $1.34 Million
Q3 2018 Nov 07, 2018	BUY	$167.73 - $192.74 $1.36 Million - $1.56 Million	8,094 New	8,094 $1.56 Million

Others Institutions Holding VRTX

# of Institutions

1,789

Shares Held

224M

Call Options Held

1.63M

Put Options Held

1.47M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $127B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mc Guire Investment Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mc Guire Investment Group, LLC with notifications on news.

Account

Mc Guire Investment Group, LLC Vertex Pharmaceuticals Inc Transaction History